{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:01:18Z","timestamp":1791856878156,"version":"4.3.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802015"],"award-info":[{"award-number":["81802015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Chronic hepatitis B (CHB) virus infection is one of the leading causes of cirrhosis and liver cancer. Although the major drugs against CHB including nucleos(t)ide analogs and PEG-interferon can effectively control human hepatitis B virus (HBV) infection, complete cure of HBV infection is quite rare. Targeting host factors involved in the viral life cycle contributes to developing innovative therapeutic strategies to improve HBV clearance. In this study, we found that the mRNA and protein levels of SIRT2, a class III histone deacetylase, were significantly upregulated in CHB patients, and that SIRT2 protein level was positively correlated with HBV viral load, HBsAg\/HBeAg levels, HBcrAg, and ALT\/AST levels. Functional analysis confirmed that ectopic SIRT2 overexpression markedly increased total HBV RNAs, 3.5-kb RNA and HBV core DNA in HBV-infected HepG2-Na<jats:sup>+<\/jats:sup>\/taurocholate cotransporting polypeptide cells and primary human hepatocytes. In contrast, SIRT2 silencing inhibited HBV transcription and replication. In addition, we found a positive correlation between SIRT2 expression and HBV RNAs synthesis as well as HBV covalently closed circular DNA transcriptional activity. A mechanistic study suggested that SIRT2 enhances the activities of HBV enhancer I\/HBx promoter (EnI\/Xp) and enhancer II\/HBc promoter (EnII\/Cp) by targeting the transcription factor p53. The levels of HBV EnI\/Xp and EnII\/Cp-bound p53 were modulated by SIRT2. Both the mutation of p53 binding sites in EnI\/Xp and EnII\/Cp as well as overexpression of p53 abolished the effect of SIRT2 on HBV transcription and replication. In conclusion, our study reveals that, in terms of host factors, a SIRT2-targeted program might be a more effective therapeutic strategy for HBV infection.<\/jats:p>","DOI":"10.3389\/fmicb.2022.836446","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:49:28Z","timestamp":1652942968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters"],"prefix":"10.3389","volume":"13","author":[{"given":"Dai-Qing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Na","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.3390\/v9060156","article-title":"The role of cccDNA in HBV maintenance","volume":"9","author":"Allweiss","year":"2017","journal-title":"Viruses"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e55415","DOI":"10.7554\/eLife.55415","article-title":"Host sirtuin 2 as an immunotherapeutic target against tuberculosis","volume":"9","author":"Bhaskar","year":"2020","journal-title":"Elife"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev.biochem.73.011303.073651","article-title":"The Sir2 family of protein deacetylases","volume":"73","author":"Blander","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"18211","DOI":"10.1073\/pnas.0706987104","article-title":"Blood gene expression signatures predict exposure levels","volume":"104","author":"Bushel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/hep.26278","article-title":"SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B\/glycogen synthase kinase-3\u03b2\/\u03b2-catenin signaling","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1002\/ijc.33118","article-title":"The role of SIRT2 in cancer: a novel therapeutic target","volume":"147","author":"Chen","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e01824","DOI":"10.1128\/JVI.01824-16","article-title":"Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with type I interferon (IFN) receptor 1 to repress IFN\/JAK\/STAT signaling","volume":"91","author":"Chen","year":"2017","journal-title":"J. Virol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00262-019-02337-5","article-title":"Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model","volume":"68","author":"Chen","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx","volume":"74","author":"Cheng","year":"2021","journal-title":"J. Hepatol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bbrc.2018.01.127","article-title":"HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis","volume":"496","author":"Cheng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.antiviral.2016.01.008","article-title":"PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression","volume":"127","author":"Chu","year":"2016","journal-title":"Antivir. Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nri3295","article-title":"Evolutionary conflicts between viruses and restriction factors shape immunity","volume":"12","author":"Duggal","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/imm.12841","article-title":"Genome-wide host RNA signatures of infectious diseases: discovery and clinical translation","volume":"153","author":"Gliddon","year":"2018","journal-title":"Immunology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hern\u00e1ndez Borrero","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e13205","DOI":"10.1111\/cmi.13205","article-title":"Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis","volume":"22","author":"Herrscher","year":"2020","journal-title":"Cell. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12263-010-0170-1","article-title":"Gene expression profiles in human peripheral blood mononuclear cells as biomarkers for nutritional in vitro and in vivo investigations","volume":"5","author":"Hofmann","year":"2010","journal-title":"Genes Nutr."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.3390\/v9030056","article-title":"Complete and incomplete hepatitis B virus particles: formation, function, and application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3389\/fphar.2019.01270","article-title":"SIRT6 inhibitor, OSS_128167 restricts hepatitis B virus transcription and replication through targeting transcription factor peroxisome proliferator-activated receptors \u03b1","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ccell.2016.03.011","article-title":"A SIRT2-selective inhibitor promotes c-Myc Oncoprotein degradation and exhibits broad anticancer activity","volume":"29","author":"Jing","year":"2016","journal-title":"Cancer Cell"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","article-title":"Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator","volume":"13","author":"Lain","year":"2008","journal-title":"Cancer Cell"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coviro.2021.04.009","article-title":"Hepatitis B virus-host interactions and novel targets for viral cure","volume":"49","author":"Ligat","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"790036","DOI":"10.3389\/fcimb.2021.790036","article-title":"Interferon gamma-inducible protein 16 of peripheral blood mononuclear cells may sense hepatitis B virus infection and regulate the antiviral immunity","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/liv.14364","article-title":"Can we cure hepatitis B virus with novel direct-acting antivirals?","volume":"40","author":"Martinez","year":"2020","journal-title":"Liver Int."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00018-020-03694-6","article-title":"The regulatory roles of p53 in cardiovascular health and disease","volume":"78","author":"Men","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/cells10020300","article-title":"Mechanisms of coronavirus Nsp1-mediated control of host and viral gene expression","volume":"10","author":"Nakagawa","year":"2021","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-related NAD-dependent protein deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/emboj\/17.2.544","article-title":"p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53","volume":"17","author":"Ori","year":"1998","journal-title":"EMBO J."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-981-13-9151-4_3","article-title":"The regulation of HBV transcription and replication","volume":"1179","author":"Oropeza","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e00955","DOI":"10.1128\/JVI.00955-18","article-title":"Sirtuin 2 isoform 1 enhances hepatitis B virus RNA transcription and DNA synthesis through the AKT\/GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"92","author":"Piracha","year":"2018","journal-title":"J. Virol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e00926","DOI":"10.1128\/JVI.00926-20","article-title":"An alternatively spliced Sirtuin 2 isoform 5 inhibits hepatitis B virus replication from cccDNA by repressing epigenetic modifications made by histone lysine Methyltransferases","volume":"94","author":"Piracha","year":"2020","journal-title":"J. Virol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepat."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hep.29912","article-title":"SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases","volume":"68","author":"Ren","year":"2018","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1042\/CS20200970","article-title":"LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor","volume":"134","author":"Ren","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1128\/JVI.02861-13","article-title":"Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1","volume":"88","author":"Ren","year":"2014","journal-title":"J. Virol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.virol.2014.05.027","article-title":"Cyclin D2 plays a regulatory role in HBV replication","author":"Song","year":"2014","journal-title":"Virology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/gut.2005.065086","article-title":"CREB\/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2\/S promoter","volume":"54","author":"Tacke","year":"2005","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.jhep.2021.06.038","article-title":"Novel function of SART1 in HNF4\u03b1 transcriptional regulation contributes to its antiviral role during HBV infection","volume":"75","author":"Teng","year":"2021","journal-title":"J. Hepatol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coviro.2018.10.001","article-title":"Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse","volume":"32","author":"Todt","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antivir. Res."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"174264","DOI":"10.1016\/j.ejphar.2021.174264","article-title":"Tenovin-1 inhibited dengue virus replication through SIRT2","volume":"907","author":"Wan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.arr.2019.100961","article-title":"SIRT2: controversy and multiple roles in disease and physiology","volume":"55","author":"Wang","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41564-020-0678-0","article-title":"Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation","volume":"5","author":"Wei","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41467-021-21850-9","article-title":"Hepatitis B virus cccDNA is formed through distinct repair processes of each strand","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jprot.2017.09.002","article-title":"RNA interference-mediated knockdown of SIRT1 and\/or SIRT2 in melanoma: identification of downstream targets by large-scale proteomics analysis","volume":"170","author":"Wilking-Busch","year":"2018","journal-title":"J. Proteome"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tim.2020.07.002","article-title":"Virus-host cell interplay during hepatitis E virus infection","volume":"29","author":"Wi\u00dfing","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: formation, regulation and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antivir. Res."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"elife"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1042\/CS20210392","article-title":"SIRT7 restricts HBV transcription and replication through catalyzing desuccinylation of histone H3 associated with cccDNA minichromosome","volume":"135","author":"Yu","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.7150\/ijms.26125","article-title":"AGK2, A SIRT2 inhibitor, inhibits hepatitis B virus replication in vitro and in vivo","volume":"15","author":"Yu","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fcell.2018.00154","article-title":"Host cell Rab GTPases in hepatitis B virus infection","volume":"6","author":"Zeyen","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/jvh.12136","article-title":"Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection","volume":"21","author":"Zhang","year":"2014","journal-title":"J. Viral Hepat."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3892\/mmr.2019.10398","article-title":"SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1\/2 signaling pathway","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1002\/hep.30497","article-title":"A functional variant in ubiquitin conjugating enzyme E2 L3 contributes to hepatitis B virus infection and maintains covalently closed circular DNA stability by inducing degradation of Apolipoprotein B mRNA editing enzyme catalytic subunit 3A","volume":"69","author":"Zhou","year":"2019","journal-title":"Hepatology"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.836446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:50:10Z","timestamp":1652943010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.836446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":55,"alternative-id":["10.3389\/fmicb.2022.836446"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.836446","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"article-number":"836446"}}